Jenny Hoffmann, PhD Appointed CEO of Biorithm
Jenny Hoffmann, PhD, has been appointed CEO of Biorithm, a global women’s medical technology company dedicated to developing cutting-edge solutions for personalized connected maternity care, including Femom, a comprehensive remote obstetric monitoring system.
“I’m honored to join Biorithm in the goal of leveraging the power of digital health and data science to address individual patient and clinician needs during pregnancy. As both a mother and an innovator, I’m incredibly inspired by our vision to enhance data-driven decisions and provide access to affordable, high quality care to improve perinatal outcomes for mothers and babies across the globe,” said Hoffmann.
